Figure 6: Achievement of 24-hour ambulatory PA target of <130/80 mmHg after 12 weeks of treatment, initiated with OM 20 mg and up-titrated to OM/HCTZ 40/25 mg in a stepwise manner, in all elderly patients (>65 years) (A) and in the subgroup of 'very old' patients (>75 years) (B), respectively. Elaborated from (8).